US04010L1035 - Common Stock

Taking everything into account, **ARCC** scores **4** out of 10 in our fundamental rating. **ARCC** was compared to 220 industry peers in the **Capital Markets** industry. **ARCC** has a medium profitability rating, but doesn't score so well on its financial health evaluation. **ARCC** has a correct valuation and a medium growth rate.

In the past year **ARCC** was profitable.

Each year in the past 5 years **ARCC** has been profitable.

In the past 5 years **ARCC** reported 4 times negative operating cash flow.

Looking at the **Return On Assets**, with a value of **6.45%**, **ARCC** is in the better half of the industry, outperforming **72.09%** of the companies in the same industry.

Looking at the **Return On Equity**, with a value of **13.62%**, **ARCC** is in the better half of the industry, outperforming **66.98%** of the companies in the same industry.

With a **Return On Invested Capital** value of **4.29%**, **ARCC** perfoms like the industry average, outperforming **53.95%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **ARCC** is below the industry average of **7.91%**.

The 3 year average ROIC (**3.86%**) for **ARCC** is below the current ROIC(**4.29%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6.45% | ||

ROE | 13.62% | ||

ROIC | 4.29% |

ROA(3y)5.53%

ROA(5y)4.98%

ROE(3y)12.51%

ROE(5y)10.98%

ROIC(3y)3.86%

ROIC(5y)4.04%

In the last couple of years the **Profit Margin** of **ARCC** has declined.

The **Operating Margin** of **ARCC** (**48.86%**) is better than **82.33%** of its industry peers.

In the last couple of years the **Operating Margin** of **ARCC** has declined.

In the last couple of years the **Gross Margin** of **ARCC** has remained more or less at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 48.86% | ||

PM (TTM) | 59.76% | ||

GM | 50.35% |

OM growth 3Y-2.94%

OM growth 5Y-1.6%

PM growth 3Y22.04%

PM growth 5Y-1.93%

GM growth 3Y-3.38%

GM growth 5Y-1.02%

The number of shares outstanding for **ARCC** has been increased compared to 1 year ago.

Compared to 5 years ago, **ARCC** has more shares outstanding

The debt/assets ratio for **ARCC** has been reduced compared to a year ago.

Based on the Altman-Z score of **0.88**, we must say that **ARCC** is in the distress zone and has some risk of bankruptcy.

A Debt/Equity ratio of **1.05** is on the high side and indicates that **ARCC** has dependencies on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.05 | ||

Debt/FCF | N/A | ||

Altman-Z | 0.88 |

ROIC/WACCN/A

WACCN/A

With a **Quick ratio** value of **1.27**, **ARCC** perfoms like the industry average, outperforming **53.49%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.27 | ||

Quick Ratio | 1.27 |

The **Earnings Per Share** has been growing slightly by **6.14%** over the past year.

The **Earnings Per Share** has been growing slightly by **7.12%** on average over the past years.

Looking at the last year, **ARCC** shows a quite strong growth in **Revenue**. The Revenue has grown by **16.01%** in the last year.

EPS 1Y (TTM)6.14%

EPS 3Y11.06%

EPS 5Y7.12%

EPS Q2Q%5.17%

Revenue 1Y (TTM)16.01%

Revenue growth 3Y20.05%

Revenue growth 5Y14.35%

Sales Q2Q%19.09%

Based on estimates for the next years, **ARCC** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-4.09%** on average per year.

Based on estimates for the next years, **ARCC** will show a small growth in **Revenue**. The Revenue will grow by **5.59%** on average per year.

EPS Next Y0.26%

EPS Next 2Y-2.88%

EPS Next 3Y-4.09%

EPS Next 5YN/A

Revenue Next Year10.92%

Revenue Next 2Y5.59%

Revenue Next 3YN/A

Revenue Next 5YN/A

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

Based on the **Price/Earnings** ratio of **8.47**, the valuation of **ARCC** can be described as reasonable.

Based on the **Price/Earnings** ratio, **ARCC** is valued a bit cheaper than the industry average as 74.88% of the companies are valued more expensively.

The **Price/Forward Earnings** ratio is **9.17**, which indicates a very decent valuation of **ARCC**.

66.51% of the companies in the same industry are more expensive than **ARCC**, based on the **Price/Forward Earnings** ratio.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **20.38**, **ARCC** is valued rather cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 8.47 | ||

Fwd PE | 9.17 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates **ARCC** does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)33.19

PEG (5Y)1.19

EPS Next 2Y-2.88%

EPS Next 3Y-4.09%

With a **Yearly Dividend Yield** of **9.40%**, **ARCC** is a good candidate for dividend investing.

Compared to an average S&P500 **Dividend Yield** of **2.32**, **ARCC** pays a better dividend.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 9.4% |

The dividend of **ARCC** has a limited annual growth rate of **3.99%**.

Dividend Growth(5Y)3.99%

Div Incr Years3

Div Non Decr Years3

DP63.3%

EPS Next 2Y-2.88%

EPS Next 3Y-4.09%

**ARES CAPITAL CORP**

NASDAQ:ARCC (8/9/2024, 7:00:00 PM)

After market: 20.5 0 (0%)**20.5**

**+0.07 (+0.34%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap12.60B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 9.4% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 8.47 | ||

Fwd PE | 9.17 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)33.19

PEG (5Y)1.19

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 6.45% | ||

ROE | 13.62% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 48.86% | ||

PM (TTM) | 59.76% | ||

GM | 50.35% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.11

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.05 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.27 | ||

Quick Ratio | 1.27 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)6.14%

EPS 3Y11.06%

EPS 5Y

EPS Q2Q%

EPS Next Y0.26%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)16.01%

Revenue growth 3Y20.05%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y